化工网/ 资讯中心/ 化工产品/ 艾塞那肽 | Exendin-4 - MedChemExpress

艾塞那肽 | Exendin-4 - MedChemExpress

2022年11月24日 09:00   化工产品  

MedChemExpress LLC 发布 访问商铺

关键词:艾塞那肽

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。

艾塞那肽

CAS No. : 141758-74-9

MCE 国际站:Exendin-4

产品活性:Exendin-4 (Exenatide) 是由 39 个氨基酸组成的多肽。它是长效的 glucagon-like peptide-1 受体激动剂,IC50 值为 3.22 nM。

研究领域:GPCR/G Protein

作用靶点:GCGR

In Vitro: In human umbilical vein endothelial cells, exendin-4 significantly increases NO production, endothelial NO synthase (eNOS) phosphorylation, and GTP cyclohydrolase 1 (GTPCH1) level in a dose-dependent manner. Exendin-4 shows cytotoxic effects to MCF-7 breast cancer cells with IC50 of 5 μM at 48 hour.

In Vivo: Both low- and high-dose exendin-4 treatment in ob/ob mice improve serum ALT and reduce serum glucose, and calculated HOMA scores compared with control. Exendin-4-treated ob/ob mice sustain a marked reduction in the net weight gain in the final 4 weeks of the study period. Animals treated with exendin-4 have more pancreatic acinar inflammation, more pyknotic nuclei and weigh significantly less than control rats. Exendin-4 treatment is associated with lower leptin levels as well as lower HOMA values in rats. Exenatide causes dose-dependent relaxation of rat thoracic aorta, which is evoked via the GLP-1 receptor and is mediated mainly by H2S but also by NO and CO.

相关产品:Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  FDA-Approved Drug Library  |  Antiviral Compound Library  |  Drug Repurposing Compound Library  |  Anti-diabetic Compound Library  |  NMPA-Approved Drug Library  |  FDA Approved & Pharmacopeial Drug Library  |  Anti-Breast Cancer Compound Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Rare Diseases Drug Library  |  Children’s Drug Library  |  Peptide Library  |  Protein-protein Interaction Inhibitor Library  |  EMA-Approved Drug Library  |  Non-steroidal Anti-Inflammatory Compound Library  |  PF-06291874  |  Neuropeptide Y, porcine  |  HAEGTFTSDVS  |  Glucagon receptor antagonists-5  |  Oxyntomodulin TFA  |  Tirzepatide TFA  |  Liraglutide  |  GLP-1R agonist 1  |  Exendin-4 acetate  |  GLP-1(7-37) acetate  |  V-0219  |  Glucagon (1-29), bovine, human, porcine  |  GPCR modulator-1  |  VU0453379  |  Cotadutide  |  GLP-1 receptor agonist 7  |  Avexitide  |  Glucagon-like peptide 1 (1-37), human TFA  |  Semaglutide TFA  |  GLP-1R modulator C5  |  Glucagon (19-29), human  |  Efinopegdutide  |  [Des-His1,Glu9]-Glucagon amide TFA  |  Exendin-3/4 (59-86)  |  FTSDVSKQMEEEAVRLFIEWLKNGGPSSGAPPPS  |  Cochinchinenin C  |  TT-OAD2  |  GLP-1R Antagonist 1

热门产品线:重组蛋白  |  化合物库  |  天然产物  |  染料试剂  |  PROTAC  |  同位素标记物  |  寡核苷酸

Trending products:Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

1000+ Inhibitors&Agonists 作用于20多条经典信号通路

30+ Screening Libraries 疾病机制研究的高效工具
CCK8 Kit | Cell Counting Kit-8
FDA-Approved 药物筛选库
Inhibitor Cocktails 蛋白酶, 磷酸酶 & 去乙酰化酶
Top Publications Citing Use of MCE
MCE Hotline: 4008203792 | 中国现货 - 全球文献引用 - 高纯度高品质 - 全方位技术支持
微信二维码
  • 微信公众号二维码
  • 关注官方微信公众号
  • 微信二维码
  • 微信扫码联系客服
平台客服
平台在线客服